29th Apr 2025 07:00
Diaceutics - Notice of Results & Presentations
New York, Belfast and London, 29 April 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, will announce its audited final results for the year ended 31 December 2024 on Tuesday, 13 May 2025.
Analyst Presentation:
A webinar presentation for analysts and investors will be held at 1400 BST (0900 EDT) on Tuesday, 13 May 2025. Those wishing to attend can register their interest using the following link:
https://us06web.zoom.us/webinar/register/WN_tH4xZK9CR4iL4FkvLAW0bw
Investor Meet Company Presentation:
A webinar presentation for investors will be held via the Investor Meet Company platform at 1530 BST (1030 EDT) on Tuesday, 13 May 2025. The presentation is open to all existing and potential shareholders and registration can be completed via the following link:
https://www.investormeetcompany.com/diaceutics-plc/register-investor
Enquiries:
Diaceutics PLC | |
Ryan Keeling, Chief Executive Officer Nick Roberts, Chief Financial Officer | Tel: +44 (0)28 9040 6500
|
Canaccord Genuity Limited (Nomad & Broker) | Tel: +44 (0)20 7523 8000 |
Simon Bridges, Andrew Potts, Harry Rees |
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®.
Related Shares:
Diaceutics